Adaptive Biotechnologies
Adaptive Biotechnologies

Adaptive Biotechnologies

Measured by AhrefsDR63Ahrefs DR: 63/100. Above median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed47Site Speed: 47/100. Bottom 25%. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust89Data Trust: 89/100. Top 25%. Measured by StartupHub.ai. Median 61.

Leveraging the adaptive immune system to diagnose and treat disease.

2009ActiveSeattle, United States

About

Adaptive Biotechnologies harnesses the adaptive immune system to power the Age of Immune Medicine, translating immune system genetics into actionable data. Their core offerings include clonoSEQ for Measurable Residual Disease assessment and an Immune Medicine Platform that informs clinical trials and the development of transformative medicines. They serve clinicians, biopharma companies, and patients by transforming how diseases are detected, monitored, and treated.

Key facts

Website
adaptivebiotech.com
Headquarters
Seattle, United States
Founded
2009
Total funding
$300M (Series D)
Business model
B2B

Funding rounds

Funding rounds raised by Adaptive Biotechnologies
DateRoundAmountLead investors
1 May 2019Series D$300MFidelity

Tech stack

Detected on adaptivebiotech.com, last scanned 1 Nov 2026.

Compliance
HIPAA
Frontend
jQuery
Auth
Auth0
Analytics
Google Tag Manager
SEO
Yoast SEO
CMS / Builders
WordPress
Email provider
Cisco IronPort, Google Workspace
Email marketing
Mailgun

Adaptive Biotechnologies scores 63. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Adaptive Biotechnologies trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Adaptive Biotechnologies is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Adaptive Biotechnologies raised?

Adaptive Biotechnologies has raised a total of $300M in funding. The most recent round on record is Series D.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Adaptive Biotechnologies